A carregar...
Deferasirox for managing transfusional iron overload in people with sickle cell disease
BACKGROUND: Sickle cell disease (SCD) is a group of genetic haemoglobin disorders, that occurs in about 2.2 per 1000 births worldwide. Increasingly, some people with SCD develop secondary iron overload due to occasional red blood cell transfusions or are on long‐term transfusion programmes for e.g....
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2014
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6489379/ https://ncbi.nlm.nih.gov/pubmed/24893174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007477.pub3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|